Literature DB >> 2119678

Influence of exercise on nitroglycerin plasma concentrations after transdermal application.

R A Lefebvre1, M G Bogaert, O Teirlynck, A Sioufi, J P Dubois.   

Abstract

Nitroglycerin plasma concentrations following transdermal application were measured in nine healthy subjects during supine rest position or during supine rest interrupted by sitting or exercising for 20 min. Sitting led to almost doubling of the average plasma concentrations (0.31 ng ml-1 before sitting, 0.55 ng ml-1 at the end of the sitting period), but exercise was accompanied by a much more marked increase in average plasma concentrations, which reached its maximum 5 min after ending exercise (0.22 ng ml-1 before exercise, 1.26 ng ml-1 5 min after the exercise period). Changes of bioavailability as well as of systemic clearance might be involved in the exercise-induced increase in plasma nitroglycerin concentrations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119678      PMCID: PMC1368231          DOI: 10.1111/j.1365-2125.1990.tb03778.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperature.

Authors:  T F Barkve; K Langseth-Manrique; J E Bredesen; K Gjesdal
Journal:  Am Heart J       Date:  1986-09       Impact factor: 4.749

2.  Cardiac output is an apparent determinant of nitroglycerin pharmacokinetics in rats.

Authors:  H L Fung; A Blei; S Chong
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

3.  Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans.

Authors:  J Mooy; B Arends; J van Kemenade; R Boehm; K H Rahn; M van Baak
Journal:  J Cardiovasc Pharmacol       Date:  1986 Sep-Oct       Impact factor: 3.105

4.  The effects of moderate sustained exercise on the pharmacokinetics of nitroglycerine.

Authors:  S Weber; D de Lauture; E Rey; T Darragon; J P Severins; A Ditisheim; G Olive; M Degeorges
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

5.  Influence of posture on plasma nitroglycerin.

Authors:  S H Curry; H R Kwon
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

6.  Organic nitrates: relationship between biotransformation and rational angina pectoris therapy.

Authors:  P Needleman; S Lang; E M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1972-06       Impact factor: 4.030

Review 7.  Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.

Authors:  M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 8.  Effect of acute and chronic exercise on hepatic drug metabolism.

Authors:  M Døssing
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

9.  Blood vessel uptake and metabolism of organic nitrates in the rat.

Authors:  H L Fung; S C Sutton; A Kamiya
Journal:  J Pharmacol Exp Ther       Date:  1984-02       Impact factor: 4.030

10.  Quantitative determination of nitroglycerin in human plasma by capillary gas chromatography with electron-capture detection.

Authors:  A Sioufi; F Pommier
Journal:  J Chromatogr       Date:  1985-04-12
View more
  7 in total

1.  Heating and cooling of the nitroglycerin patch application area modify the plasma level of nitroglycerin.

Authors:  T O Klemsdal; K Gjesdal; J E Bredesen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  The effect of transdermal nitroglycerin on exercise tolerance in relation to patch application time--a meta-analysis.

Authors:  T O Klemsdal; K Gjesdal
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

3.  Novel pharmacokinetic modelling of transdermal nitroglycerin.

Authors:  B Auclair; G Sirois; A H Ngoc; M P Ducharme
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

4.  Transdermal patch drug delivery interactions with exercise.

Authors:  Thomas L Lenz; Nicole Gillespie
Journal:  Sports Med       Date:  2011-03-01       Impact factor: 11.136

Review 5.  Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.

Authors:  P A Todd; K L Goa; H D Langtry
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.

Authors:  Satoru Hashimoto; Atsuko Kobayashi
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of nitrates.

Authors:  M G Bogaert
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.